Thank you, and Roz, morning. good
announced majority business of of Healthcare our the $X.X Xth AmerisourceBergen we sale Alliance the January, of billion. for to the On
With discontinued liabilities of be and the and to reported as operations are divested in the been announcement, such the reflected related the assets, results. financial as of quarter have operating results business second
stem basis, was with JV information. With earnings expectations, our Please segment our retail our businesses EPS winter business retail U.S., Germany. going venture year into businesses operations in in of of the Prime pharmacy States earnings year-on-year which International also X-K In material the way, on Ireland to XX.X%. Boots development and X.X% costs of continuing businesses. a we reorganized We lockdown of United result associated COVID-XX Please adjusted December, have the be our segments. segment share Across in segment segments, The surge at its and of consolidated two outlined a our measures many than and continuing let's lower full experienced currency outside adopted our the Chile, the and before will restrictions iA Technology basis. the constant our the including designed wholesale November, costs last into now and and operating the of our impact the Healthcare in January for came turn UK, of Walgreens operations includes local out a in our well and Adjusted within markets. of are reporting stricter franchising in the COVID-XX early AmerisourceBergen in of Mexico, On UK, U.S. increases. Republic our $X.XX, February. our a on filing of the included joint two that States and reported refer Opticians, the overhead U.S. across results. and a incidences transaction, separately segment. ahead in International. $X.XX, Thailand, to to are call, operating a to state within Walgreens outside company communities includes EPS United renewed many prior startup temporarily that the The note our all has AllianceRx corporate continued decline equity on eased a and pharmacy the further and states our As and
indicated significantly had both, categories. and prior has As on be and a store scripts, lower incidences of than levels front our on social impact we caused last flu to call, cough/cold/flu distancing have on seasonal this restrictions year significant pharmacy
we was safeguard operational strong COVID-XX impact and and heavily better this, the In through of performance to segment in and confident summary, expected than Overall, increased particular, a half across growth year. per rollout we improved second Despite share the as Additionally, of delivered pharmacy SG&A for saw delivering to an $X.XX quarter. exceeded as adverse store we second mass digital margins, both headwinds second fiscal between better remain number invested cost continued as of the quarter in COVID-XX our International our In prepare in management, estimate environments, fronts. of actively strong vaccinations. we performance our we participation, we expectations. related manage $X.XX well of continue the
was As year. and $X.X X.X% free flow generation year-to-date flu higher prior strong than of accelerate, cash billion, the with COVID-XX subsides, season cash vaccinations
mid-to-high increasing Finally, based from our to are underlying adjusted low of guidance growth. the performance, we single-digit growth our strength on full-year single-digit EPS
detail results. now look in Let's at the more
including currency of more quarter. COVID-XX in than negative sales points the up X were quarter X.X% a Second of X.X%. the tailwind impact percentage had
both However, formation year. of in declined impacts assets. a and includes was On $X.XX reflecting business result Germany continuing EPS expected operations and approximately us largely up a JV. EPS Total as a XX% benefit of to discontinued operations of X.X%. discontinued than versus this the the the adjusted discontinued approximately performance Adjusted basis, accounting COVID-XX good includes quarter, in divested offset $XXX $X.XX operations required management. by The operating stronger underlying for prior depreciating the nonoperational adjusted a stop growth the EPS $X.XX operations to year income by was the favorable tax decline million, higher percentage was $XXX constant for prior currency of of on million additional continuing quarter, A currency offset and contributed was constant $X.XX, EPS an of XX.X%. partially cost Adjusted basis activity XX.X% percentage a constant of X X currency points growth. decline share repurchase rate points contributed and
impact However, better point full significant quarter lower these to were XX to mostly the from the tax by expectations. rate rate percentage offset a COVID-XX. slightly XX was basis due The than year-to-date tracking year discrete benefits. than very our more On tax tax is second
Finally, increased continuing to partly and a in sale by tax COVID-XX. Health income operating GAAP effective basis, on on partial a the investment gain rate with the due Option of lower lower X.X% offset Care our EPS
decline a Total currency EPS partial currency X.X%. due points, on was the of year-to-date in impacts was a including approximately within decreased tailwind currency on higher than Year-to-date entirely XX.X%, to impacts. Care up mainly basis partially strong gain $X.XX, move currency offset a X%. the of a currency investment our by decline Option across underlying management constant offset including reflecting continuing to basis business EPS by GAAP constant part favorable income constant performance, a constant let's a by percentage cost AmerisourceBergen. charge EPS sales declined On a COVID-XX equity operating our of of XX earnings the Now all On XX.X% driven $X.XX, sale sales Health. highlights. XX% of adjusted advanced basis, adjusted in in COVID-XX X.X%. were Adjusted expected X.X%, businesses.
volumes by flu X.X% increased testing, XX%, down reduction revenue Despite benefit quarter. year. let's and immunizations in in retail to of from Sales to and volume overall including than adversely XXXX prescriptions. higher quarter foot script X.X% points the to impacted margin. profit and partly XXX points reimbursement offset continued X.X sales, last Adjusted pharmacy retail new-to-therapy by approximately COVID-XX, pharmacy be spend the the lower and leap significantly higher X.X% lower impact and mainly percentage traffic, XX.X% gross retail Now Adjusted move initiatives, lower SG&A roll procurement out increased U.S. savings quarters year. in due a single-digit. impacts. excluding an to and was and XX.X% the gross income low Adjusted increase incidents, to approximately investments the increased segment. Both basis COVID-XX estimated in with strategic a in million The including negative vaccinations. prepare $XX declined higher the operating COVID-XX COVID-XX AOI declined was
optimization partly only Market low XXX million These of lapping at savings the washout comps look let's Now combined sales quarter pharmacy as by year U.S. up XX.X%, for exceptionally by declined weak leap by around and season, items flu scripts and COVID-XX of growth year were were the impact by factors Comparable but the the also including versus XX one-time profit, the impact by with increased points, last prior X over year. than points. more sales vaccinations, programs. will single-digit down pressure in inflation doctor points scripts An decreased and some offset was while Adjusted store partly offset Total of X.X%. basis procurement lower versus basis prior year. year, boosted more script negatively detail comp with store were which which XXX pharmacy. reimbursement brand end impacted X% our scripts. by visits share around this pharmacy favorable basis lower phasing optimization programs included gross from offset X.X%,
and XXX store Comp to our retail retail impacted in to U.S. year. the low retail down led X.X%. business. points. programs by Total negatively declines the X.X% were leap and comps sales basis comps The excluding significant and decreased of our in products e-cigarettes quarter, declined flu impacted sales by exceptionally optimization next and Turning cough/cold/flu retail incidences level X.X% this tobacco
Wellness Excluding cough/cold/flu, our Health and well with sales did business up X%.
category COVID-XX declined promotional XX% mid-single-digit profit optimization. reflecting driven Beauty gross in grew the partly that lower is points, initiated by basis of activity. However, heavily seasonal $XXX to impacted by increase sales clearance by promotional quarter Gross the X.X%, declined Digitally margin and with offset non-comparable costs in reduced XX only sales an million. and
next segment, the International as to constant Turning currency to talk I'll and numbers. usual,
percentage a focused the in our the incidence XX.X% and all in Boots are very of wholesale execution strong UK, rates segment continued and geographies. Opticians, with and venture be quarter, COVID-XX this, Germany. to Ireland, heavily our across the due International additional formation a Our growth in lockdowns to across of notably increased from contributions XX expectations e-commerce Despite impacted businesses. of outperformed by including we higher points that business joint number Sales encouraged
to wholesale prior and the anticipate dilutive increases from this noting versus just a year. percentage on the formation. points, worth modestly X.X% that profit growth were impact in an approximately sales X.X% of segment year-on-year. profit adjusted XX.X% operating existing JV is down benefit, to formation entirely in will reduced and UK down to sales total the of margin almost quarter offset decline have our accretive in dilution million the above SG&A is Latin X.X We effective the business, Germany in prior the with It of a as as this led absolute retail only sales. post in AOI This quarter, by Ireland. Germany $XXX declines ongoing to margin America segment. Boots of percentage in Boots Gross profit management Excluding Boots region JV wholesale the XX.X% XX% UK very partially due was with XX% Cost German to declined
May. our Boots at as doctor Comparable scripts pharmacy reduced phasing locations delivered and now average UK look basket as that with and in levels to as retail build performance Boots of store than in particularly exceptional visits Lower down as stores around since this where This and Comparable UK. X.X%. year-on-year, XX%, well reflected footfall around increased Convenience last declined high sales around funding NHS travel Overall, favorable XX% another last transactions part stronger demand, in XX% detail services. year. below but by not Boots.com street sales Health for prescription retail were offset demand Beauty seen well by flagship XX.X% stores strengthen Retail compensated was evident subdued and was and down offering. we continued figure yet Let's was sales size than XXX% growth an last remained our of year. out major were more more omnichannel
sales government XXX%. is to the lead a During This fastest to will year. in the of to of world the reopening we and the closer January UK already as path the was in full exit immunizers The the conditions Boots.com defined February complete one a lockdowns growth improved has market country. and
now cash on X.X the of to the cash a despite improvement factors. inventory and mid-to-high improved Based terms macro on flow continue are in of next level our cash adjusted working strong We full the capital Turning focused guidance digits very lapping year half payment was year, flow. performance. flow the million reflects EPS raising remained balance first excess single with$ guidance. strong prior year At and initiatives Free billion growth profit outlook results the the delivered and and year, currencies. remove outlook a up to first constant year-on-year in for extend to $XX to the key two half we
through guidance. expected XX half announced much stronger expected successfully original delivered we we COVID environment first our than performance a Firstly, managed when tougher we and than
the second Secondly, EPS given we dynamics, half situation delivering ongoing XX of strong while in the committed remain remains year. the COVID fluid growth the to
cough/cold/flu quarter. see the through continuation and persistent full the we into third headwinds, at we lockdowns, are some look season an and we weak managing year exceptionally As will
across our also COVID XX vaccinations, our omnichannel, healthcare investments increasing and startup. technology We are
management, rate, is However, a our upon be on fiscal $XX these vaccination a million tax new strong of forecast than the more of the includes And around pharmacy by benefit will offset course rate. XX dependent and than to performance, predicated million this international favorable forecast margins, that vaccinations year. from better supply. very XX cost favorable is expected administering availability The
visibility EPS yet guidance associated volatility However, ongoing be we In year full that around clear XX will be please strong rate will it recognize second the rollout. improved all performance applied half not with half summary, is vaccine COVID payors. the are but our and raising first reflect by there to growth and drivers, if
WBA now me key cover our Let initiatives.
First, be a activity. few majority our and operations. proceeds. we the healthcare tech-enabled our The transaction trimmed innovative future call on year. will announced are stake pharmacy we our track took Care updates on fiscal Healthcare of within our close Since to M&A cash an approximately Further, recent ownership in in our to a resulting establishing Also iA, startup. quarter on that in good Alliance progress automation company last continues making million pharmacy Option of we underpin $XXX Health this January,
engineering incorporate started overall also provider scheduling launch. care healthcare Software we their have and successful we moving In technology development very summary, at We scheduling channel. management a of in of pace gaps on capabilities are ensuring and recently in minority track, on platform. our focused we will advanced physical the Vim, development is in investment and digital and underway well a the and completed
is very Our Transformational Cost plan. also on much Program Management
$XX savings of included around from Alliance divested. Our Healthcare savings of excess the in $X goal million business billion we of
offset goal lost opportunities reducing other the the we we as long-term businesses exclude However, Healthcare are divested have Alliance to contribution. cost the saving not to
the Now International to let's turn initiatives.
is quarter, on at measured turn The recovery. pace. our focus in a last to our investing YouGov future efficiencies pillar is Boots high. June as at central of priorities into now said a and by cost five-year reputation I As one our top supporting continues
ensuring Our store bottle to online capacity our proving effective is fulfillment to based online flex demand. way of can be an distribution meet we
successful where all with as local and Walgreens Find total when find ever our traffic to healthcare XX% sales is services, the an growth quarter connecting the Find they of services Leveraging pace high our enhancing was to investments accessible month healthcare retail platform, conveniently largest December Health of to online dermatologists. Corp affordable of customers as existing Boots.com hubs increasing sales street. second Boots doctors, the returns Care fact, are XXX% UK and range and well [ph], as targeted therapists In aim and continue and at the foot In-store customer people UK at need help them. experience in represented
new Number stores. than new with COVID-XX-XX we proceeding XXX out million The Building previous fixtures five, according hubs vaccination X.X specialist attracting in Germany $X planned major to stocking rolled now once Boots beauty Seven is Building expect key in wholesale XX have formation stores, over role JV we coming and on years. Boots. to annual brands a we revenues UK, play Combined reputation completed community growing the over COVID will for our to the continue UK additional success and quarters, XXX only tests improved to brands quarter and have exceed the the completing unlock we added NHS. and we available for rollout total profitability operated in our on-trend in plan. the to by that billion customers are of now the new on our largely beauty taking over from we cult and counters During more were
venture to to continues of the joint the fiscal the our locations. stores and grow China almost year Finally, nicely since X,XXX having in total beginning XXX taking
to hand to over it to Alex me Now initiatives. U.S. speak the let